Diagnosis and Treatment of

Area of Science:

• Microbiology
• Infectious Diseases
• Gastroenterology

Background:

• Helicobacter pylori infection is a primary cause of upper gastrointestinal diseases and a precursor to gastric cancer.
• Increasing antibiotic resistance to standard treatments (clarithromycin, levofloxacin, metronidazole) complicates H. pylori eradication.
• Suboptimal management by physicians, particularly primary care physicians (PCPs), exacerbates the H. pylori resistance problem.

Purpose of the Study:

• To highlight the challenges in H. pylori infection management due to rising antibiotic resistance.
• To emphasize the potential of molecular methods in diagnosing antibiotic resistance and guiding personalized H. pylori treatments.
• To underscore the need for improved physician adherence to H. pylori treatment guidelines.

Main Methods:

• Review of current challenges in H. pylori eradication regimens.
• Discussion of the role of molecular diagnostics in detecting antibiotic resistance.
• Analysis of physician management practices regarding H. pylori infection.

Main Results:

• Antibiotic resistance is a significant global healthcare issue impacting H. pylori treatment efficacy.
• Molecular methods show promise for personalized H. pylori treatment but are not yet widely adopted.
• Current H. pylori diagnosis and treatment by physicians often fall short of consensus recommendations.

Conclusions:

• Effective H. pylori infection management requires addressing antibiotic resistance and improving physician compliance with guidelines.
• Personalized treatment approaches, potentially enabled by molecular diagnostics, are crucial for overcoming resistance.
• Novel strategies are needed to enhance H. pylori management and ensure high eradication rates.